BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26619165)

  • 1. Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study.
    Georgiadou SP; Pongas G; Fitzgerald NE; Lewis RE; Rytting M; Marom EM; Kontoyiannis DP
    J Pediatric Infect Dis Soc; 2012 Jun; 1(2):125-35. PubMed ID: 26619165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective, International Cohort Study of Invasive Mold Infections in Children.
    Wattier RL; Dvorak CC; Hoffman JA; Brozovich AA; Bin-Hussain I; Groll AH; Castagnola E; Knapp KM; Zaoutis TE; Gustafsson B; Sung L; Berman D; Halasa NB; Abzug MJ; Velegraki A; Sharma TS; Fisher BT; Steinbach WJ
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):313-22. PubMed ID: 26582870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
    Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
    Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mold infections of the central nervous system in patients with hematologic cancer or stem cell transplantation (2000-2016): Uncommon, with improved survival but still deadly often.
    Economides MP; Ballester LY; Kumar VA; Jiang Y; Tarrand J; Prieto V; Torres HA; Kontoyiannis DP
    J Infect; 2017 Dec; 75(6):572-580. PubMed ID: 28919347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
    Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D
    J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy.
    Patel HP; Perissinotti AJ; Patel TS; Bixby DL; Marshall VD; Marini BL
    Open Forum Infect Dis; 2019 May; 6(5):ofz176. PubMed ID: 31123689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive mold infections in lung transplant recipients.
    Doligalski CT; Benedict K; Cleveland AA; Park B; Derado G; Pappas PG; Baddley JW; Zaas DW; Harris MT; Alexander BD
    Am J Transplant; 2014 Jun; 14(6):1328-33. PubMed ID: 24726020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
    Klingspor L; Saaedi B; Ljungman P; Szakos A
    Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies.
    Dutta A; Ikwuezunma A; Castellanos MI; Brackett J; Reddy K; Mahajan P; Marshburn AM; Kamdar K; Paek H; Palazzi DL; Rabin KR; Scheurer ME; Gramatges MM
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29228. PubMed ID: 34268879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.
    Hill JA; Dalai SC; Hong DK; Ahmed AA; Ho C; Hollemon D; Blair L; Maalouf J; Keane-Candib J; Stevens-Ayers T; Boeckh M; Blauwkamp TA; Fisher CE
    Clin Infect Dis; 2021 Dec; 73(11):e3876-e3883. PubMed ID: 33119063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
    Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
    Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review.
    Al-Rezqi A; Hawkes M; Doyle J; Richardson SE; Allen U
    Pediatr Transplant; 2009 Aug; 13(5):545-52. PubMed ID: 18992060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey.
    Kontoyiannis DP; Shah EC; Wurster S; Aitken SL; Graviss L; Raad II; Chemaly RF
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz138. PubMed ID: 31024975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
    Perkhofer S; Lass-Flörl C; Hell M; Russ G; Krause R; Hönigl M; Geltner C; Auberger J; Gastl G; Mitterbauer M; Willinger B; Knöbl P; Resch G; Waldner R; Makrai A; Hartmann G; Girschikofsky M; Greil R
    Int J Antimicrob Agents; 2010 Dec; 36(6):531-6. PubMed ID: 20947312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
    Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
    J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
    Campo M; Lewis RE; Kontoyiannis DP
    J Infect; 2010 May; 60(5):331-7. PubMed ID: 20138081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.
    Rojas R; Molina JR; Jarque I; Montes C; Serrano J; Sanz J; Besalduch J; Carreras E; Tomas JF; Madero L; Rubio D; Conde E; Sanz MA; Torres A
    Mediterr J Hematol Infect Dis; 2012; 4(1):e2012011. PubMed ID: 22348193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients.
    Li L; Wang J; Zhang W; Yang J; Chen L; Lv S
    Scand J Infect Dis; 2012 Feb; 44(2):100-7. PubMed ID: 22066677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
    Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
    Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
    Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.